登录 +0086-27-65522453 sales@sun-shinechem.com

Brivaracetam 编号 : 16122906

化学信息

产品英文名称Brivaracetam
Iupac 化学名称Brivaracetam 
同义词UCB 34714; UCB-34714; UCB34714; Briviact 
英文同义词UCB 34714; UCB-34714; UCB34714; Briviact 
分子式C11H20N2O2 
分子量212.293 
SmileCc1nc(cs1)COc2ccc(cc2)C[C@@H]([C@@H](CN(CC(C)C)S(=O)(=O)c3ccc4c(c3)OCO4)O)NC(=O)O[C@H]5CO[C@@H]6[C@H]5CCO6
InChiKeyJORVRJNILJXMMG-OLNQLETPSA-N
InChiInChI=1S/C33H41N3O10S2/c1-20(2)14-36(48(39,40)25-8-9-29-30(13-25)45-19-44-29)15-28(37)27(35-33(38)46-31-17-43-32-26(31)10-11-41-32)12-22-4-6-24(7-5-22)42-16-23-18-47-21(3)34-23/h4-9,13,18,20,26-28,31-32,37H,10-12,14-17,19H2,1-3H3,(H,35,38)/t26-,27-,28+,31-,32+/m0/s1
Cas357336-20-0
MDLMFCD13152385

技术数据

外观crystalline solid 
纯度98% 
可溶性Soluble in DMSO 
存储3 years -20ºCpowder 
运输条件Shipped under ambient temperature as non-hazardous chemical. 
质量控制

产品详情

Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties approved for the treatment of epilepsy. Brivaracetam is believed to act by binding to the ubiquitous synaptic vesicle glycoprotein 2A (SV2A), like levetiracetam. SV2A plays a role in exocytosis of various neurotransmitters. Brivaracetam was approved to treat partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs. 

结构

16122906 - Brivaracetam | CAS 357336-20-0

包装

规格价格
登录 to get price

快速订购

Change

联系我们